Sarah Brand
2PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Dec 15, 2021
Cost-effectiveness of second-line empagliflozin versus liraglutide for type 2 diabetes in the United States.Odette S Reifsnider, Pratik Pimple, Sarah Brand
|Nov 25, 2020
Cost-effectiveness analysis of empagliflozin versus sitagliptin as second-line therapy for treatment in patients with type 2 diabetes in the United States.Odette Reifsnider, Anuraag Kansal, Pratik Pimple
Pageof 1
